Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Rhythm Pharmaceuticals
RYTM
$7.25B
| $28.6M | 0.02% |
621,892
-443,853
| -42% | -$14M |
|
477
Rocket Pharmaceuticals
RCKT
$351M
| $28.4M | 0.02% |
949,905
+47,810
| +5% | +$1.06M |
|
478
Lennar Class A
LEN
$20.2B
| $28.4M | 0.02% |
196,685
-68,631
| -26% | -$8.27M |
|
479
Silgan Holdings
SLGN
$4.34B
| $28.3M | 0.02% |
626,030
+576,950
| +1,176% | +$24.3M |
|
480
Wells Fargo
WFC
$258B
| $28M | 0.02% |
568,736
+66,165
| +13% | +$2.86M |
|
481
RLI Corp
RLI
$5.62B
| $27.9M | 0.02% |
419,808
+9,202
| +2% | +$618K |
|
482
Phillips Edison & Co
PECO
$5.45B
| $27.8M | 0.02% |
761,091
-77
| -0% | -$2.69K |
|
483
Oshkosh
OSK
$8.82B
| $27.5M | 0.02% |
253,334
-46,166
| -15% | -$4.46M |
|
|
NSA
484
DELISTED
National Storage Affiliates Trust
NSA
| $27M | 0.02% |
652,172
+9,573
| +1% | +$321K |
|
485
Under Armour
UAA
$2.91B
| $26.9M | 0.02% |
3,059,226
+146,772
| +5% | +$1.13M |
|
486
Ambarella
AMBA
$3.25B
| $26.8M | 0.02% |
437,237
-3,543
| -0.8% | -$193K |
|
487
Landstar System
LSTR
$5.75B
| $26.8M | 0.02% |
138,215
+23,818
| +21% | +$4.22M |
|
488
Simmons First National
SFNC
$3.38B
| $26.6M | 0.02% |
1,340,808
-53,307
| -4% | -$892K |
|
489
Monarch Casino & Resort
MCRI
$2.19B
| $26.5M | 0.02% |
383,511
+949
| +0.2% | +$60.4K |
|
490
AN2 Therapeutics
ANTX
$192M
| $26.3M | 0.02% |
1,279,975
-108,975
| -8% | -$1.82M |
|
491
NCR Voyix
VYX
$1.12B
| $26.2M | 0.02% |
1,549,569
-976,957
| -39% | -$15.6M |
|
492
Target
TGT
$65.6B
| $25.7M | 0.02% |
180,273
+111,308
| +161% | +$13.6M |
|
493
Weatherford International
WFRD
$6.07B
| $25.7M | 0.02% |
262,386
-26,512
| -9% | -$2.46M |
|
494
Disc Medicine
IRON
$3.03B
| $25.6M | 0.02% |
443,178
-57,202
| -11% | -$2.93M |
|
495
Xometry
XMTR
$4.69B
| $25.5M | 0.02% |
711,048
+2,409
| +0.3% | +$51.7K |
|
|
JIB
496
DELISTED
Janus Henderson Sustainable & Impact Core Bond ETF
JIB
| $25.5M | 0.02% |
604,368
-27,935
| -4% | -$1.13M |
|
497
Alamo Group
ALG
$1.92B
| $25.4M | 0.02% |
121,028
+413
| +0.3% | +$75.5K |
|
498
Franklin FTSE Japan ETF
FLJP
$4.01B
| $25.4M | 0.02% |
907,679
-16,826
| -2% | -$450K |
|
499
Atlanta Braves Holdings Series B
BATRK
$3.26B
| $25.4M | 0.02% |
640,792
+91,390
| +17% | +$3.33M |
|
500
Artisan Partners
APAM
$2.82B
| $25.1M | 0.02% |
567,935
-381,334
| -40% | -$14.4M |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.